Related Experiment Video

Updated: May 18, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Pre-existing immunity in human challenge studies of influenza transmission

Julian W Tang

    The Lancet. Infectious Diseases
    |September 29, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
    04:47

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

    Published on: February 23, 2018

    Influenza A Virus Studies in a Mouse Model of Infection
    10:44

    Influenza A Virus Studies in a Mouse Model of Infection

    Published on: September 7, 2017

    Related Experiment Videos

    Last Updated: May 18, 2026

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
    04:47

    A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

    Published on: February 23, 2018

    Influenza A Virus Studies in a Mouse Model of Infection
    10:44

    Influenza A Virus Studies in a Mouse Model of Infection

    Published on: September 7, 2017

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

    Articles linked to this work by shared authors, journal, and citation graph.

    Changes in respiratory virus seasonality across the COVID-19 pandemic: a multicenter comparative study in Leicester, Rotterdam, Hong Kong, and Christchurch.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

    Vulnerabilities in pandemic responses.

    Public health·2026

    HIV-Now Another Long Term Chronic Condition?

    Viruses·2026

    The landscape of aerosol transmission after COVID-19.

    Current opinion in pulmonary medicine·2026

    Comparing school term and holiday seasonal respiratory virus detection rates in hospitalised children, 2019-2024.

    Diagnostic microbiology and infectious disease·2026

    Influenza PA Substitutions and Genetic Diversity of A(H1N1)pdm09, A(H3N2), and B/Victoria Viruses in Japan During the 2023-2024 Season.

    Viruses·2026

    Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial.

    The Lancet. Infectious diseases·2026

    Is a tiered classification framework needed for sexually transmitted infections?

    The Lancet. Infectious diseases·2026

    Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review.

    The Lancet. Infectious diseases·2026

    Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study.

    The Lancet. Infectious diseases·2026

    Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation study.

    The Lancet. Infectious diseases·2026

    Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications.

    The Lancet. Infectious diseases·2026

    IL-1α protects intestinal barrier in murine visceral leishmaniasis.

    mBio·2026

    Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative ability.

    eLife·2026

    Amphiregulin shapes mitochondrial delivery and immune modulation by microvescicles.

    iScience·2026

    Pathogenesis and Triazole Resistance in Aspergillus fumigatus: A Narrative Review Across the Host Immune Spectrum and One Health Context.

    Infection and drug resistance·2026

    Safety and immunogenicity of inactivated human Rotavirus vaccine in young children and infants: a randomized, placebo-controlled, double-blind, phase I clinical trial.

    Nature communications·2026

    Epigenetic repression of IL-1β by C1QBP restricts Dectin-1-mediated host defense against murine invasive candidiasis.

    Nature communications·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us